Anti-C3d antibody conjugates and methods of detecting complement activation
US11191851B2 · kind B2 · utility
0Cited by
42References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 16, 2019 |
| Grant date | Dec 7, 2021 |
| Priority date | — |
| Expiry date | Sep 16, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2469/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided herein, inter alia, are compositions and methods of using the same for detecting complement activation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.